Adaptogenic medicinal mushrooms

Adaptogenic Mushrooms - What does this term mean and where does it come from?

Adaptogen. A word that is appearing more and more frequently on labels, in wellness blogs and on social media. Sometimes accompanied by bold promises. Sometimes without any explanation. And almost always without context.

Before we talk about adaptogenic mushrooms, we should understand what this term actually means, who coined it and why it is not just a buzzword.

A concept with scientific origins

The term "adaptogen" did not originate in marketing. It was coined in 1947 by the Soviet pharmacologist Nikolai Lazarev to describe substances that can increase the body's resistance to stress – whether physical, chemical or biological in nature. The core idea: not to act on a specific symptom, but to help the body adapt to adverse conditions.

In the following years, the researcher Israel Brejman refined the concept based on three specific criteria. An adaptogenic substance had to be safe, non-specific – meaning it acted on several systems at the same time – and help normalize body functions regardless of the type of imbalance.

A strict framework. Quite different from the modern use of the term.

From tradition to modern science

Many of the substances we study under this term today have been present in traditional healing systems for centuries: in Chinese medicine, Ayurveda and the traditions of various regions of Asia and Siberia.

Reishi, cordyceps, chaga. None of them waited for a Soviet pharmacologist to give them a name. They were part of traditions in which empirical knowledge about their use had been gathered over generations.

What modern research has contributed is the ability to study these species using analytical methods: to identify their ingredients, characterize extracts and investigate possible biological mechanisms of action. In some cases, these studies make it possible to formulate hypotheses related to historically described uses. But tradition and clinical evidence are not the same, and they should not be confused.

Why the term adaptogen causes confusion today

The problem with the term "adaptogen" is twofold.

On the one hand, marketing has stripped it of its precision. It is applied to any plant or mushroom for which there is even the slightest tradition of use, without distinction based on evidence or mechanisms of action. The result is confusion and justified distrust.

On the other hand, the European regulation on health claims does not recognize the term "adaptogen" as an authorized claim. In the European commercial context, its use without further context can be problematic from a regulatory perspective.

The concept itself remains useful as a theoretical framework. However, only if it is applied strictly: by explaining what it means, what scientific evidence exists and what limitations there are.

Reishi, cordyceps and chaga: three mushrooms, three profiles

These three are frequently associated with the term "adaptogen" in current literature. However, they are not equivalent to one another, and there is no European regulatory classification that defines them as such.

Each has its own composition. Reishi contains beta-glucans and a variety of triterpenes. Cordyceps exhibits different profiles depending on the species or strain used. Chaga contains triterpenoids and a high concentration of phenolic compounds.

To speak of them as if they were interchangeable – linked merely by a label – is an oversimplification. Under a single term, we find different species, different raw materials and chemical profiles that deserve to be studied individually.

A case that requires a nuanced view: the lion's mane mushroom

The lion's mane mushroom (Hericium erinaceus) is also frequently listed under the term "adaptogen". However, most of the scientific interest it has generated in recent years comes from a different area.

Among its best-studied compounds are hericenones, which occur mainly in the fruiting body, and erinacines, which have been studied particularly in the mycelium. Both families of compounds have sparked research interest in mechanisms related to neurotrophic factors such as NGF (nerve growth factor). A specific and promising research approach, which is based primarily on preclinical studies and for which clinical evidence is still limited.

This is a clear example of why the term "adaptogen" can cause confusion rather than clarity. Classifying the lion's mane mushroom in the same category as reishi or chaga says nothing about any of the three.

A term that requires a more precise definition

The term "adaptogen" is neither a promise nor a seal of quality. It is a concept with scientific origins, its own history and defined criteria, which – like so many others in the wellness sector – has been adopted by marketing and stripped of its context.

Only if you understand its origins can it continue to be useful. Because very different species, ingredients and research directions can stand behind the exact same term.

And knowing these differences is far more interesting than being satisfied with a simple label.

Would you like to learn more about the properties of the individual mushroom species? Then check out the articles on the individual species at keynaturals.net.